First Trust Advisors Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
First Trust Exchange-Traded Fund IV First Trust Tactical High Yield ETF
HYLS
|
+$184M |
| 2 |
First Trust NYSE Arca Biotechnology Index Fund
FBT
|
+$158M |
| 3 |
First Trust Health Care AlphaDEX Fund
FXH
|
+$136M |
| 4 |
First Trust Dow Jones Internet Index Fund ETF
FDN
|
+$123M |
| 5 |
First Trust Consumer Staples AlphaDEX Fund
FXG
|
+$123M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$120M |
| 2 |
Conagra Brands
CAG
|
+$72.2M |
| 3 |
IMGN
Immunogen Inc
IMGN
|
+$61.5M |
| 4 |
RAD
Rite Aid Corporation
RAD
|
+$55.9M |
| 5 |
MNK
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
|
+$50.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 17.59% |
| 2 | Technology | 12.87% |
| 3 | Consumer Discretionary | 10.2% |
| 4 | Consumer Staples | 9.25% |
| 5 | Industrials | 7.37% |
Similar funds
First Trust Advisors's Q4 2014 Portfolio in Review
As of Q4 2014, First Trust Advisors held 2,390 positions worth $29.6B, up 17% from $25.4B the previous quarter. Its ten largest holdings account for 7.9% of the portfolio.
First Trust Advisors deployed $2.91B of net new capital in Q4 2014, opening 174 new positions and adding to 1,221 existing holdings. Its largest new stake was Alnylam Pharmaceuticals: 857,683 shares worth $83.2M.
By sector, the portfolio is most concentrated in Healthcare at 18% of assets, up from 18% a quarter earlier, followed by Technology and Consumer Discretionary.
On the sell side, the largest reduction was iShares iBoxx $ High Yield Corporate Bond ETF, an estimated $120M trimmed.
- First Trust Advisors's largest Q4 2014 buy was Alnylam Pharmaceuticals: 857,683 shares worth $83.2M.
- First Trust Advisors added most to First Trust Exchange-Traded Fund IV First Trust Tactical High Yield ETF in Q4 2014, an estimated $184M increase.
- First Trust Advisors's biggest Q4 2014 reduction was iShares iBoxx $ High Yield Corporate Bond ETF, cutting an estimated $120M.
- First Trust Advisors fully exited Immunogen Inc in Q4 2014, selling an estimated $61.5M.
- First Trust Advisors's ten largest holdings make up 7.9% of its $29.6B portfolio in Q4 2014.
- First Trust Advisors opened 174 new positions and closed 147 in Q4 2014.
- First Trust Advisors's portfolio value rose 17% quarter-over-quarter to $29.6B.
Based on First Trust Advisors's 13F filing for Q4 2014, filed 13 Feb 2015.